466.50
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Rad Laboratories Inc | BIO.B | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 466.50 | 0.00 | 0.00 | 0.00 | 466.50 | 20:00:00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 466.50 | USD |
Bio Rad Laboratories Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 13.83B | 29.65M | 232.34k | $ 2.31B | $ 1.31B | 58.22 | 8.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.00 | $ - | 0.00% | 1.00 | 17.60% |
Bio Rad Laboratories News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO.B Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 457.70 | 474.00 | 457.70 | 460.87 | 64 | 8.80 | 1.92% |
| 1 Month | 453.40 | 474.00 | 429.35 | 452.63 | 44 | 13.10 | 2.89% |
| 3 Months | 409.53 | 492.70 | 409.53 | 446.34 | 140 | 56.97 | 13.91% |
| 6 Months | 378.565 | 492.70 | 320.02 | 397.95 | 214 | 87.94 | 23.23% |
| 1 Year | 311.52 | 492.70 | 307.28 | 375.35 | 312 | 154.98 | 49.75% |
| 3 Years | 225.30 | 492.70 | 210.7108 | 319.64 | 319 | 241.20 | 107.06% |
| 5 Years | 150.13 | 492.70 | 124.50 | 270.85 | 252 | 316.37 | 210.73% |
Bio Rad Laboratories Description
| Bio-Rad Laboratories Inc manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe. |
